Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Ultragenyx Pharmaceutical Inc. buy Barclays PLC

Ultragenyx Pharmaceutical Inc.
Start price
€28.40
24.11.25 / 50%
Target price
€43.44
24.11.26
Performance (%)
-34.15%
Price
€19.00
13.03.26
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC for Ultragenyx Pharmaceutical Inc. is performing very badly with a performance of -34.15%. This prediction currently runs until 24.11.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Ultragenyx Pharmaceutical Inc. 4.396% 4.396%
iShares Core DAX® -1,10 % -6,08 %
iShares Nasdaq 100 0,33 % 2,33 %
iShares Nikkei 225® -1,08 % -7,99 %
iShares S&P 500 -0,06 % 0,88 %

Comments by Barclays_PLC for this prediction

In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Prediction Buy
Perf. (%) -34.15%
Target price 43.435
Change
Ends at 24.11.26

Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Barclays PLC from $81.00 to $50.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat

Barclays PLC 
0
Report Share
24.11.25

Stopped prediction by Barclays_PLC for Ultragenyx Pharmaceutical Inc.

buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€45.20
06.08.24
€74.24
06.08.25
-48.67%
07.08.25

Barclays PLC 
06.08.24 50%